| 1 | Effects of Aging on Glucose and Lipid Metabolism in Mice | 6.8 | 12 | Citations (PDF) |
| 2 | The bidirectional relationship between metabolism and cell cycle control | 12.0 | 51 | Citations (PDF) |
| 3 | Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis | 13.7 | 55 | Citations (PDF) |
| 4 | Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability | 0.7 | 17 | Citations (PDF) |
| 5 | A CRISPRi/a screening platform to study cellular nutrient transport in diverse microenvironments | 16.3 | 39 | Citations (PDF) |
| 6 | Why do patients with cancer die? | 60.7 | 123 | Citations (PDF) |
| 7 | Cancer tissue of origin constrains the growth and metabolism of metastases | 17.1 | 32 | Citations (PDF) |
| 8 | Short-term post-fast refeeding enhances intestinal stemness via polyamines | 37.9 | 55 | Citations (PDF) |
| 9 | RAD21
promotes oncogenesis and lethal progression of prostate cancer | 7.5 | 8 | Citations (PDF) |
| 10 | Slow TCA flux and ATP production in primary solid tumours but not metastases | 37.9 | 275 | Citations (PDF) |
| 11 | Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenase | 36.3 | 152 | Citations (PDF) |
| 12 | A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability | 6.7 | 39 | Citations (PDF) |
| 13 | Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer | 13.7 | 61 | Citations (PDF) |
| 14 | Ablative radiotherapy improves survival but does not cure autochthonous mouse models of prostate and colorectal cancer | 4.5 | 1 | Citations (PDF) |
| 15 | Manipulating mitochondrial electron flow enhances tumor immunogenicity | 36.3 | 113 | Citations (PDF) |
| 16 | Approaches to Study Tumor Metabolism in Mice | 6.6 | 0 | Citations (PDF) |
| 17 | Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening | 13.7 | 23 | Citations (PDF) |
| 18 | Cells use multiple mechanisms for cell-cycle arrest upon withdrawal of individual amino acids | 6.3 | 23 | Citations (PDF) |
| 19 | Interactions with stromal cells promote a more oxidized cancer cell redox state in pancreatic tumors | 10.9 | 31 | Citations (PDF) |
| 20 | Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression | 7.3 | 69 | Citations (PDF) |
| 21 | Regulation of chromatin accessibility by the histone chaperone CAF-1 sustains lineage fidelity | 13.7 | 31 | Citations (PDF) |
| 22 | Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma | 3.8 | 22 | Citations (PDF) |
| 23 | Cancer cells depend on environmental lipids for proliferation when electron acceptors are limited | 17.1 | 80 | Citations (PDF) |
| 24 | The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer | 6.8 | 51 | Citations (PDF) |
| 25 | Nucleotide imbalance decouples cell growth from cell proliferation | 16.3 | 189 | Citations (PDF) |
| 26 | Effect of exercise on tumor markers – Is exercise anti-tumorigenic in humans?: A scoping review of preliminary clinical investigations | 5.0 | 7 | Citations (PDF) |
| 27 | Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression | 25.1 | 202 | Citations (PDF) |
| 28 | Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth | 4.2 | 22 | Citations (PDF) |
| 29 | Increased demand for NAD+ relative to ATP drives aerobic glycolysis | 13.3 | 534 | Citations (PDF) |
| 30 | Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes | 1.1 | 9 | Citations (PDF) |
| 31 | The metabolic landscape of RAS-driven cancers from biology to therapy | 22.5 | 245 | Citations (PDF) |
| 32 | Fatty acid synthesis is required for breast cancer brain metastasis | 22.5 | 308 | Citations (PDF) |
| 33 | Cell-programmed nutrient partitioning in the tumour microenvironment | 37.9 | 964 | Citations (PDF) |
| 34 | Differential substrate use in EGF‐ and oncogenic KRAS‐stimulated human mammary epithelial cells | 5.4 | 5 | Citations (PDF) |
| 35 | Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells | 13.7 | 92 | Citations (PDF) |
| 36 | Metabolomics in cancer research and emerging applications in clinical oncology | 251.5 | 562 | Citations (PDF) |
| 37 | The CAT-SIR is out of the bag: tumors prefer host rather than dietary nutrients | 3.9 | 1 | Citations (PDF) |
| 38 | Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells | 17.1 | 118 | Citations (PDF) |
| 39 | PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart | 18.0 | 66 | Citations (PDF) |
| 40 | Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer | 1.1 | 4 | Citations (PDF) |
| 41 | Low glycaemic diets alter lipid metabolism to influence tumour growth | 37.9 | 298 | Citations (PDF) |
| 42 | Methionine synthase is essential for cancer cell proliferation in physiological folate environments | 17.1 | 82 | Citations (PDF) |
| 43 | Cancer‐associated mutations in human pyruvate kinase M2 impair enzyme activity | 2.7 | 26 | Citations (PDF) |
| 44 | Metabolism in the Tumor Microenvironment | 5.4 | 78 | Citations (PDF) |
| 45 | Monitoring and modeling of lymphocytic leukemia cell bioenergetics reveals decreased ATP synthesis during cell division | 13.7 | 37 | Citations (PDF) |
| 46 | MFSD7C switches mitochondrial ATP synthesis to thermogenesis in response to heme | 13.7 | 44 | Citations (PDF) |
| 47 | Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance | 25.2 | 130 | Citations (PDF) |
| 48 | A metastasis map of human cancer cell lines | 37.9 | 415 | Citations (PDF) |
| 49 | REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks | 7.5 | 45 | Citations (PDF) |
| 50 | Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition | 25.1 | 256 | Citations (PDF) |
| 51 | Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1 | 22.5 | 70 | Citations (PDF) |
| 52 | A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study | 3.4 | 20 | Citations (PDF) |
| 53 | Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer | 33.0 | 442 | Citations (PDF) |
| 54 | Transcriptional activation of macropinocytosis by the Hippo pathway following nutrient limitation | 4.6 | 3 | Citations (PDF) |
| 55 | Increased PHGDH expression promotes aberrant melanin accumulation | 2.9 | 13 | Citations (PDF) |
| 56 | Identification of DHODH as a therapeutic target in small cell lung cancer | 12.5 | 137 | Citations (PDF) |
| 57 | Cellular redox state constrains serine synthesis and nucleotide production to impact cell proliferation | 17.1 | 154 | Citations (PDF) |
| 58 | Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer | 1.1 | 51 | Citations (PDF) |
| 59 | Determinants of nutrient limitation in cancer | 6.7 | 69 | Citations (PDF) |
| 60 | Phenotypic selection with an intrabody library reveals an anti-apoptotic function of PKM2 requiring Mitofusin-1 | 5.0 | 16 | Citations (PDF) |
| 61 | Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting | 25.2 | 240 | Citations (PDF) |
| 62 | Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance | 3.8 | 127 | Citations (PDF) |
| 63 | Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer | 13.7 | 70 | Citations (PDF) |
| 64 | The redox requirements of proliferating mammalian cells | 2.2 | 146 | Citations (PDF) |
| 65 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 | 13.3 | 6,013 | Citations (PDF) |
| 66 | Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer | 1.1 | 19 | Citations (PDF) |
| 67 | Lack of evidence for substrate channeling or flux between wildtype and mutant isocitrate dehydrogenase to produce the oncometabolite 2-hydroxyglutarate | 2.2 | 13 | Citations (PDF) |
| 68 | Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth | 7.3 | 104 | Citations (PDF) |
| 69 | Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in GliomaCell, 2018, 175, 101-116.e25 | 33.6 | 345 | Citations (PDF) |
| 70 | Aspartate is an endogenous metabolic limitation for tumour growth | 16.3 | 341 | Citations (PDF) |
| 71 | Serine Synthesis via PHGDH Is Essential for Heme Production in Endothelial Cells | 25.2 | 186 | Citations (PDF) |
| 72 | Isoform-specific deletion of PKM2 constrains tumor initiation in a mouse model of soft tissue sarcoma | 4.8 | 27 | Citations (PDF) |
| 73 | Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting | 25.2 | 190 | Citations (PDF) |
| 74 | Microenvironmental regulation of cancer cell metabolism: implications for experimental design and translational studies | 2.0 | 121 | Citations (PDF) |
| 75 | Altered exocrine function can drive adipose wasting in early pancreatic cancer | 37.9 | 141 | Citations (PDF) |
| 76 | JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition | 10.6 | 74 | Citations (PDF) |
| 77 | Preparation of Lipid-Stripped Serum for the Study of Lipid Metabolism in Cell Culture | 0.4 | 26 | Citations (PDF) |
| 78 | Understanding the Intersections between Metabolism and Cancer Biology | 33.6 | 2,046 | Citations (PDF) |
| 79 | Biochemical Underpinnings of Immune Cell Metabolic Phenotypes | 22.6 | 143 | Citations (PDF) |
| 80 | Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation | 3.8 | 54 | Citations (PDF) |
| 81 | Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis | 33.0 | 630 | Citations (PDF) |
| 82 | Targeting Metabolism for Cancer Therapy | 6.2 | 865 | Citations (PDF) |
| 83 | mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a NutrientCell, 2017, 171, 642-654.e12 | 33.6 | 436 | Citations (PDF) |
| 84 | Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions | 13.7 | 400 | Citations (PDF) |
| 85 | Nature and Nurture: What Determines Tumor Metabolic Phenotypes? | 3.8 | 70 | Citations (PDF) |
| 86 | Critical Functions of the Lysosome in Cancer Biology | 11.8 | 203 | Citations (PDF) |
| 87 | PKM2 is not required for colon cancer initiated by APC loss | 4.8 | 36 | Citations (PDF) |
| 88 | Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence | 1.1 | 121 | Citations (PDF) |
| 89 | A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate | 11.8 | 525 | Citations (PDF) |
| 90 | Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma | 4.6 | 154 | Citations (PDF) |
| 91 | Altered metabolite levels in cancer: implications for tumour biology and cancer therapy | 60.7 | 380 | Citations (PDF) |
| 92 | Circadian Rhythm Disruption Promotes Lung Tumorigenesis | 25.2 | 508 | Citations (PDF) |
| 93 | The importance of serine metabolism in cancer | 5.4 | 379 | Citations (PDF) |
| 94 | Metabolic requirements for cancer cell proliferation | 4.8 | 127 | Citations (PDF) |
| 95 | Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin | 25.2 | 334 | Citations (PDF) |
| 96 | PKM
2, cancer metabolism, and the road ahead | 5.2 | 507 | Citations (PDF) |
| 97 | Targeting MTHFD2 in acute myeloid leukemia | 9.3 | 151 | Citations (PDF) |
| 98 | Circulating Metabolites and Survival Among Patients With Pancreatic Cancer | 4.6 | 37 | Citations (PDF) |
| 99 | Biophysical changes reduce energetic demand in growth factor–deprived lymphocytes | 5.4 | 33 | Citations (PDF) |
| 100 | Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer | 25.2 | 720 | Citations (PDF) |
| 101 | EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection | 33.6 | 126 | Citations (PDF) |
| 102 | Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells | 7.7 | 609 | Citations (PDF) |
| 103 | Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors | 33.0 | 322 | Citations (PDF) |
| 104 | The Role of Pyruvate Kinase M2 in Cancer Metabolism | 5.0 | 47 | Citations (PDF) |
| 105 | Lack of Evidence for PKM2 Protein Kinase Activity | 13.3 | 98 | Citations (PDF) |
| 106 | Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein | 3.8 | 848 | Citations (PDF) |
| 107 | Famine versus feast: understanding the metabolism of tumors in vivo | 6.7 | 179 | Citations (PDF) |
| 108 | A roadmap for interpreting 13C metabolite labeling patterns from cells | 6.8 | 624 | Citations (PDF) |
| 109 | Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells | 33.6 | 1,137 | Citations (PDF) |
| 110 | An epitope tag alters phosphoglycerate dehydrogenase structure and impairs ability to support cell proliferation | 4.8 | 38 | Citations (PDF) |
| 111 | Antibody-Mediated Neutralization of Perfringolysin O for Intracellular Protein Delivery | 4.2 | 16 | Citations (PDF) |
| 112 | SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance | 37.9 | 363 | Citations (PDF) |
| 113 | Dysregulated metabolism contributes to oncogenesis | 13.7 | 262 | Citations (PDF) |
| 114 | Pyruvate kinase: Function, regulation and role in cancer | 5.3 | 539 | Citations (PDF) |
| 115 | Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell Proliferation | 13.3 | 253 | Citations (PDF) |
| 116 | Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate | 3.7 | 189 | Citations (PDF) |
| 117 | A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect | 13.7 | 112 | Citations (PDF) |
| 118 | Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy | 3.9 | 102 | Citations (PDF) |
| 119 | Acetate metabolism in cancer cells | 4.8 | 41 | Citations (PDF) |
| 120 | Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in
IDH
-Mutant Gliomas | 6.8 | 185 | Citations (PDF) |
| 121 | Cell-State-Specific Metabolic Dependency in Hematopoiesis and LeukemogenesisCell, 2014, 158, 1309-1323 | 33.6 | 343 | Citations (PDF) |
| 122 | Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development | 33.0 | 631 | Citations (PDF) |
| 123 | A Fundamental Trade-off in Covalent Switching and Its Circumvention by Enzyme Bifunctionality in Glucose Homeostasis | 2.2 | 36 | Citations (PDF) |
| 124 | Tracing Compartmentalized NADPH Metabolism in the Cytosol and Mitochondria of Mammalian Cells | 13.3 | 548 | Citations (PDF) |
| 125 | Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells | 13.7 | 348 | Citations (PDF) |
| 126 | Metabolic targets for cancer therapy | 79.7 | 656 | Citations (PDF) |
| 127 | PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells | 33.6 | 506 | Citations (PDF) |
| 128 | Understanding Metabolic Regulation and Its Influence on Cell Physiology | 13.3 | 345 | Citations (PDF) |
| 129 | Heterogeneity of tumor-induced gene expression changes in the human metabolic network | 29.8 | 428 | Citations (PDF) |
| 130 | Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells | 37.9 | 1,632 | Citations (PDF) |
| 131 | Exploiting tumor metabolism: challenges for clinical translation | 10.6 | 71 | Citations (PDF) |
| 132 | Exon-centric regulation of pyruvate kinase M alternative splicing via mutually exclusive exons | 3.4 | 108 | Citations (PDF) |
| 133 | Detection of 2-Hydroxyglutarate in
IDH
-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy | 12.5 | 411 | Citations (PDF) |
| 134 | Small Molecule Activation of PKM2 in Cancer Cells Induces Serine Auxotrophy | 4.7 | 168 | Citations (PDF) |
| 135 | Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis | 11.8 | 755 | Citations (PDF) |
| 136 | Targeting cancer metabolism: a therapeutic window opens | 79.7 | 1,329 | Citations (PDF) |
| 137 | Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis | 25.2 | 1,063 | Citations (PDF) |
| 138 | Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation | 9.6 | 2,864 | Citations (PDF) |
| 139 | Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia | 37.9 | 1,694 | Citations (PDF) |
| 140 | Identification of small molecule inhibitors of pyruvate kinase M2 | 5.1 | 228 | Citations (PDF) |
| 141 | The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism | 7.5 | 388 | Citations (PDF) |
| 142 | Glucose Addiction of TSC Null Cells Is Caused by Failed mTORC1-Dependent Balancing of Metabolic Demand with Supply | 13.3 | 242 | Citations (PDF) |
| 143 | Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1 | 13.3 | 1,888 | Citations (PDF) |
| 144 | Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells | 36.3 | 619 | Citations (PDF) |
| 145 | Metabolism strikes back: metabolic flux regulates cell signaling: Figure 1. | 4.6 | 122 | Citations (PDF) |
| 146 | Glucose Catabolism with Resultant Formation of Reactive Oxygen Species and Local Hypoxia Modulates the Induction and Expansion of Hematopoietic Stem CellsBlood, 2010, 116, 408-408 | 4.8 | 0 | Citations (PDF) |
| 147 | Cancer-associated IDH1 mutations produce 2-hydroxyglutarate | 37.9 | 3,855 | Citations (PDF) |
| 148 | Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation | 36.3 | 14,945 | Citations (PDF) |
| 149 | Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth | 5.4 | 713 | Citations (PDF) |
| 150 | Pyruvate kinase M2 is a phosphotyrosine-binding protein | 37.9 | 946 | Citations (PDF) |
| 151 | The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth | 37.9 | 2,684 | Citations (PDF) |
| 152 | Bcl-x Complements Saccharomyces cerevisiae Genes That Facilitate the Switch from Glycolytic to Oxidative Metabolism | 2.2 | 63 | Citations (PDF) |
| 153 | Growth Factors Can Influence Cell Growth and Survival through Effects on Glucose Metabolism | 2.5 | 494 | Citations (PDF) |
| 154 | Bcl-x Promotes the Open Configuration of the Voltage-dependent Anion Channel and Metabolite Passage through the Outer Mitochondrial Membrane | 2.2 | 347 | Citations (PDF) |
| 155 | Redox regulation of p53 during hypoxia | 6.5 | 151 | Citations (PDF) |
| 156 | Role of Oxidative Phosphorylation in Bax Toxicity | 2.5 | 119 | Citations (PDF) |
| 157 | Bcl-x L Prevents the Initial Decrease in Mitochondrial Membrane Potential and Subsequent Reactive Oxygen Species Production during Tumor Necrosis Factor Alpha-Induced Apoptosis | 2.5 | 318 | Citations (PDF) |
| 158 | Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival | 7.5 | 415 | Citations (PDF) |
| 159 | The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A | 22.6 | 288 | Citations (PDF) |
| 160 | Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? | 16.3 | 599 | Citations (PDF) |
| 161 | Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms | 7.3 | 188 | Citations (PDF) |
| 162 | Bcl-xL Regulates the Membrane Potential and Volume Homeostasis of Mitochondria | 33.6 | 1,369 | Citations (PDF) |
| 163 | Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition | 0.7 | 305 | Citations (PDF) |
| 164 | Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer | 0.7 | 225 | Citations (PDF) |
| 165 | Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability | 0.7 | 575 | Citations (PDF) |
| 166 | Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma | 0.7 | 81 | Citations (PDF) |
| 167 | Understanding the Warburg Effect in Cancer | 6.6 | 33 | Citations (PDF) |
| 168 | Nutrient requirements of organ-specific metastasis in breast cancer | 37.9 | 12 | Citations (PDF) |
| 169 | Abstract 7330: Hypoxia enhances sensitivity to RAS inhibition in PDAC | 3.8 | 0 | Citations (PDF) |
| 170 | Abstract 540: Cancer cells are sensitive to methionine cycle perturbation in low-lipid environments. | 3.8 | 0 | Citations (PDF) |
| 171 | Abstract 3366: Muscle iron overload contributes to cancer cachexia-induced muscle wasting | 3.8 | 0 | Citations (PDF) |
| 172 | Abstract 337: Off-target activation of GCN2 by BRAFV600inhibitors attenuates melanoma outgrowth. | 3.8 | 0 | Citations (PDF) |
| 173 | Aconitase 2 the rescue: A safeguard against excess mitochondrial citrate | 13.3 | 0 | Citations (PDF) |
| 174 | The Influence of Diet on Cancer Progression and Treatment | 10.9 | 0 | Citations (PDF) |
